Zimmer Biomet PT receives Investment Bank Analyst Rating Update
By Yasin EbrahimInvesting.com -- The Dow fell Tuesday, weighed down by rising geopolitical tensions and a slip in Caterpillar on weaker-than-expected revenue.The Dow Jones...
Zimmer Biomet Holdings (NYSE:ZBH), Inc. ZBH posted fourth-quarter 2021 adjusted earnings per share (EPS) of $1.95, a penny short of the Zacks Consensus Estimate. The adjusted...
Zimmer Biomet (ZBH) shares rallied 4.7% in the last trading session to close at $147.68. This move can be attributable to notable volume with a higher number of shares being traded...
Zimmer Biomet Holdings (NYSE:ZBH), Inc. ZBH continues to gain market share in the Asia Pacific, Europe, the Middle East and Africa (EMEA) regions. However, slower recovery amid the...
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The Company is engaged in the design, manufacture and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, craniomaxillofacial and thoracic (CMFT) products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. It operates through four segments: Americas Orthopedics, Europe, Middle East and Africa (EMEA), Asia Pacific, and Americas Spine and Global Dental. Its knee brands include Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. Its S.E.T. brands include JuggerKnot Soft Anchor System, Gel-One1 Cross-linked Hyaluronate, Comprehensive Shoulder and others.